MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ANI Pharmaceuticals Company Profile (NASDAQ:ANIP)

Consensus Ratings for ANI Pharmaceuticals (NASDAQ:ANIP) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $53.50 (2.33% upside)

Analysts' Ratings History for ANI Pharmaceuticals (NASDAQ:ANIP)
Show:
DateFirmActionRatingPrice TargetActions
5/24/2016Standpoint ResearchDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2016GuggenheimReiterated RatingBuy$50.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016OppenheimerReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Roth CapitalReiterated RatingBuy$60.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha